UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported) April 8, 2010
CytoDyn, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Colorado 000-49908 75-3056237
--------------------------- --------------- ---------------------------
State or Other Jurisdiction Commission File IRS Employer Identification
of Incorporation Number Number
1511 Third Street, Santa Fe, NM 87505
-----------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(505) 988-5520
--------------
(Registrant's telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to be
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425).
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 5.02 Compensatory Arrangement of Certain Officers.
On April 8, 2010, the Company's Board of Directors approved compensation
arrangements for the Company's Chief Executive Officer Allen D. Allen, Chief
Financial Officer Corinne Allen and Chief Operating Officer Nader Pourhassan.
For the period April 1, 2010 through June 30, 2010 the Company's three
Executive Officers will be paid semi-monthly based upon the annual salary
amounts as set forth below:
Allen D. Allen, President and CEO $200,000 Annually
Corinne Allen, Chief Financial and Accounting Officer $150,000 Annually
Nader Pourhassan, Chief Operating Officer $200,000 Annually
SIGNATURE
Pursuant to the requirements of Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CytoDyn, Inc.
Date: April 9, 2010
/s/ Allen D. Allen
----------------------------
Allen D. Allen